InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Sankar Subramanian. Director active across 1 company, notably Nautilus Biotechnology, Inc.. Cumulatively, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €109k. Activity tracked since 15 September 2022. The latest transaction was filed on 26 September 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations